MabPlex International Ltd. Secures $59.1 Million Series A Financing Round

YANTAI, China and SAN DIEGO (PRWEB) January 29, 2019 MabPlex International Ltd , a leading and fully integrated Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China and the United States, has closed i…

Source link

Related posts

Sulfate is Incorporated into Cysteine to Trigger ABA Production and Stomatal Closure


Mistakes to Be Avoided When Preparing a Drug Launch


The Role of Abscisic Acid Signaling in Maintaining the Metabolic Balance Required for Arabidopsis Growth under Nonstress Conditions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy